Does TREPROSTINIL Cause Product dose omission? 365 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 365 reports of Product dose omission have been filed in association with TREPROSTINIL (TYVASO). This represents 0.4% of all adverse event reports for TREPROSTINIL.
365
Reports of Product dose omission with TREPROSTINIL
0.4%
of all TREPROSTINIL reports
16
Deaths
138
Hospitalizations
How Dangerous Is Product dose omission From TREPROSTINIL?
Of the 365 reports, 16 (4.4%) resulted in death, 138 (37.8%) required hospitalization, and 8 (2.2%) were considered life-threatening.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 365 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which TREPROSTINIL Alternatives Have Lower Product dose omission Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE